公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2016 | Oncogenic miR-137 contributes to cisplatin resistance via repressing CASP3 in lung adenocarcinoma | Su T.-J.; Ku W.-H.; Chen H.-Y.; Hsu Y.-C.; Hong Q.-S.; Chang G.-C.; SUNG-LIANG YU ; Chen J.J.W. | American Journal of Cancer Research | 22 | | |
2015 | Opposite Effects of M1 and M2 Macrophage Subtypes on Lung Cancer Progression | ANG YUAN ; Hsiao Y.-J.; Chen H.-Y.; HUEI-WEN CHEN ; CHAO-CHI HO ; Chen Y.-Y.; Liu Y.-C.; Hong T.-H.; SUNG-LIANG YU ; Chen J.J.W.; PAN-CHYR YANG | Scientific Reports | 255 | 229 | |
1999 | Organization of HIV-1 pol is critical for pol polyprotein processing | Chang Y.-C.; SUNG-LIANG YU ; Syu W.-J. | Journal of Biomedical Science | 1 | 0 | |
2015 | PARVA promotes metastasis by modulating ILK signalling pathway in lung adenocarcinoma | Huang A.-H.; SZU-HUA PAN ; Chang W.-H.; Hong Q.-S.; Chen J.J.W.; SUNG-LIANG YU | PLoS ONE | 24 | 24 | |
2024 | Patients with first-episode psychosis in northern Taiwan: neurocognitive performance and niacin response profile in comparison with schizophrenia patients of different familial loadings and relationship with clinical features | Yu, Shun-Chun; Hwang, Tzung-Jeng; Liu, Chih-Min; Chan, Hung-Yu; Kuo, Chian-Jue; Yang, Tsung-Tsair; Wang, Jen-Pang; Liu, Chen-Chung; Hsieh, Ming H; Lin, Yi-Ting; Chien, Yi-Ling; PO-HSIU KUO ; Shih, Ya-Wen; SUNG-LIANG YU ; Chen, Hsuan-Yu; WEI J. CHEN | BMC Psychiatry | | | |
2021 | PCDH10 exerts tumor-suppressor functions through modulation of EGFR/AKT axis in colorectal cancer | TZU-MING JAO ; WOEI-HORNG FANG ; SUNG-LIANG YU ; Yu, Sung-Liang; Weng, Wei Ting; Weng, Wei-Ting; Tsai, Ming Hong; Tsai, Ming-Hong; YA-CHIEN YANG | Cancer letters | 16 | 17 | |
2022 | PD-L1 strong expressions affect the clinical outcomes of osimertinib in treatment naïve advanced EGFR-mutant non-small cell lung cancer patients | Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; KANG-YI SU ; SUNG-LIANG YU ; Chen, Jeremy J W; Huang, Yen-Hsiang; Chang, Gee-Chen | Scientific reports | 11 | 9 | |
2019 | Perinatal polychlorinated biphenyls and polychlorinated dibenzofurans exposure are associated with DNA methylation changes lasting to early adulthood: Findings from Yucheng second generation | KANG-YI SU ; Li M.-C.; Lee N.-W.; Ho B.-C.; Cheng C.-L.; Chuang Y.-C.; SUNG-LIANG YU ; Yue Leon Guo | Environmental Research | 17 | 15 | |
2009 | Phenanthrene-based tylophorine-1 (PBT-1) inhibits lung cancer cell growth through the Akt and NF-κB pathways | Lin J.-C.; Yang S.-C.; Hong T.-M.; SUNG-LIANG YU ; Qian S.; Linyi W.; Chen H.-Y.; PAN-CHYR YANG ; Lee K.-H. | Journal of Medicinal Chemistry | 54 | 51 | |
2021 | Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia with kinase fusions in Taiwan | Hsu, Yin-Chen; Yu, Chih-Hsiang; Chen, Yan-Ming; Roberts, Kathryn G; Ni, Yu-Ling; Lin, Kai-Hsin; SHIANN-TANG JOU ; MENG-YAO LU ; Chen, Shu-Huey; Wu, Kang-Hsi; HSIU-HAO CHANG ; Lin, Dong-Tsamn; SHU-WHA LIN ; Lin, Ze-Shiang; Chiu, Wei-Tzu; Chang, Chia-Ching; Ho, Bing-Ching; Mullighan, Charles G; SUNG-LIANG YU ; YUNG-LI YANG | Scientific reports | 5 | 4 | |
2016 | Phosphatase of regenerating liver-3 inhibits invasiveness and proliferation in non-small cell lung cancer by regulating the epithelial-mesenchymal transition | Lin S.-Y.; Lee Y.-X.; SUNG-LIANG YU ; Chang G.-C.; Chen J.J.W. | Oncotarget | 7 | 7 | |
2015 | Potential therapeutic benefit of combining Gefitinib and Tamoxifen for treating advanced lung adenocarcinoma | Liu C.-M.; Chiu K.-L.; Chen T.-S.; Chang S.-M.; Yang S.-Y.; Chen L.-H.; Ni Y.-L.; Sher Y.-P.; SUNG-LIANG YU ; Ma W.-L. | BioMed Research International | 14 | 8 | |
2012 | Potential therapeutic role of Z-isochaihulactone in lung cancer through induction of apoptosis via notch signaling | Ou J.-P.; Lin H.-Y.; KANG-YI SU ; SUNG-LIANG YU ; Tseng I.-H.; Chen C.-J.; Hsu H.-C.; Chan D.-C.; Sophia Chen Y.-L. | Evidence-based Complementary and Alternative Medicine | 15 | 13 | |
2015 | Predicting outcome in patients under extracorporeal membrane oxygenation due to cardiogenic shock through dynamic change of lymphocytes and interleukins | Hong, Tsai Hsia; Hu, Fu Chang; SHUENN-WEN KUO ; Ko, Wen Je; LU-PING CHOW ; LI-MIN HSU ; SHU-CHIEN HUANG ; SUNG-LIANG YU ; YIH-SHARNG CHEN | IJC Metabolic and Endocrine | 6 | 0 | |
2016 | Predilection of contralateral upper lung metastasis in upper lobe lung adenocarcinoma patients | Huang Y.-H.; Hsu K.-H.; Tseng J.-S.; Chen K.-C.; KANG-YI SU ; Chen H.-Y.; Chang C.-S.; Chen J.J.W.; SUNG-LIANG YU ; HUEI-WEN CHEN ; Yang T.-Y.; Chang G.-C. | Journal of Thoracic Disease | 2 | 2 | |
2012 | Pretreatment Epidermal Growth Factor Receptor (EGFR) T790M mutation predicts shorter EGFR tyrosine kinase inhibitor response duration in patients with non-small-cell lung cancer | KANG-YI SU ; Chen H.-Y.; Li K.-C.; Kuo M.-L.; CHIH-HSIN YANG ; Chan W.-K.; Ho B.-C.; Chang G.-C.; JIN-YUAN SHIH ; SUNG-LIANG YU ; PAN-CHYR YANG | Journal of Clinical Oncology | 462 | 428 | |
2024 | Primary tumor consolidative therapy improves the outcomes of patients with advanced EGFR-mutant lung adenocarcinoma treated with first-line osimertinib | Wu, Jia-Jun; Tseng, Jeng-Sen; Zheng, Zhe-Rong; Chu, Cheng-Hsiang; Chen, Kun-Chieh; MONG-WEI LIN ; Huang, Yen-Hsiang; Hsu, Kuo-Hsuan; Yang, Tsung-Ying; SUNG-LIANG YU ; JIN-SHING CHEN ; CHAO-CHI HO ; Chang, Gee-Chen | Therapeutic advances in medical oncology | 0 | | |
2021 | Primary Tumor Radiotherapy During EGFR-TKI Disease Control Improves Survival of Treatment Naïve Advanced EGFR-Mutant Lung Adenocarcinoma Patients | Hsu, Kuo-Hsuan; Huang, Jing-Wen; Tseng, Jeng-Sen; Chen, Kuan-Wen; Weng, Yih-Chyang; SUNG-LIANG YU ; Yang, Tsung-Ying; Huang, Yen-Hsiang; Chen, Jeremy J W; Chen, Kun-Chieh; Chang, Gee-Chen | OncoTargets and therapy | 6 | 6 | |
2021 | Primary Tumor Resection Is Associated with a Better Outcome among Advanced EGFR-Mutant Lung Adenocarcinoma Patients Receiving EGFR-TKI Treatment | Tseng, Jeng-Sen; Hsu, Kuo-Hsuan; Zheng, Zhe-Rong; Yang, Tsung-Ying; Chen, Kun-Chieh; Huang, Yen-Hsiang; KANG-YI SU ; SUNG-LIANG YU ; Chang, Gee-Chen | Oncology | 9 | 9 | |
2014 | Prior EGFR tyrosine-kinase inhibitor therapy did not influence the efficacy of subsequent pemetrexed plus platinum in advanced chemonaïve patients with EGFR-mutant lung adenocarcinoma | Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; CHONG-JEN YU ; WEI-YU LIAO ; Tsai, Chi-Ren; Tsai, Meen-Hsin; SUNG-LIANG YU ; KANG-YI SU ; Chen, Jeremy Jw; Chen, Hsuan-Yu; MONG-HSUN TSAI | OncoTargets and Therapy | 15 | 14 | |